Antimetastatic activity of Atu027, a liposomal small interfering RNA formulation, targeting protein kinase N3 (PKN3): Final results of a phase I study in patients with advanced solid tumors.
Dirk Strumberg
No relevant relationships to disclose
Beate Schultheis
No relevant relationships to disclose
W Meyer-Sabellek
Employment or Leadership Position - Silence Therapeutics
C. Vank
Employment or Leadership Position - Silence Therapeutics
F Gebhardt
Employment or Leadership Position - Silence Therapeutics
A. Santel
Employment or Leadership Position - Silence Therapeutics
O. Keil
Employment or Leadership Position - Silence Therapeutics
K. Giese
Employment or Leadership Position - Silence Therapeutics
J. Kaufmann
Employment or Leadership Position - Silence Therapeutics
Joachim Drevs
No relevant relationships to disclose